Technology based on neuroplasticity
BrainBerry develops its technology based on the science of neuroplasticity in a personalised manner, to drive engagement with a suite of comprehensive modules and to maximise the benefits of using the mental well-being therapy.
Neuroplasticity is the brain’s ability to adapt and change chemically, structurally and functionally at any age. Our technology effectively utilises neuroplasticity within its stimulation games to enable users to “rewire” their brains associations areas and emotional responses. The potential to offset and negate some of the damage sustained through focusing on re-wiring new areas of the brain.
Your brain has the ability to change and adapt its functionalities irrespective of one’s age.
COSMA Clinical Trials
The current clinical trials are focusing on how COSMA can positively impact upon the four elements below in relation to helping people with Dementia.
Preliminary Trials – COSMA Therapy with healthy volunteers – 2018
Phase II – COSMA Neurofeedback Headset trials with Dementia Patients – 2021
Volunteer in our ongoing and Future Clinical Trials
Usability Study - COSMA Software,
Ongoing | Loughborough
5 Oakwood Drive
Loughborough, LE11 3QF
Ongoing | Chinese National Health Centre
29-30 Soho Square, Soho,
London W1D 3QS, UK
Looking for volunteers aged 60 and above to test the human factors on the Cognitive Software COSMA
Brainwave measurement Using COSMA Software
Ongoing | George Davies Centre,
15 Lancaster Rd, Leicester LE1 7HA, UK
The study will include measuring brainwaves (EEG) while playing our COSMA Software for a week to measure cognitive and mood improvements.
Improved Quality ofLife for Dementia People using COSMA Software
Interested Care Homes
The study will include measuring cognitive and mental well-being of both users and carers to help care homes provide best care on dementia and improve their CQC.